Maria Kislova
6PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 20, 2026
[Characteristics and 5-year outcomes in patients with chronic lymphocytic leukemia receiving ibrutinib (a real-world study)].U P Ergasheva, E P Panchenko, C G Chernyshenko
|Oct 24, 2025
Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL.Thomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel
|May 18, 2023
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.Eugene Nikitin, Maria Kislova, Dmitry Morozov
|Apr 14, 2023
Significant reduction in the incidence of non-coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID-19 pandemic: An additional benefit of lockdown.Maria Kislova, Andrei Petrenko, Elena A Dmitrieva
|Jan 08, 2023
Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia.Alexey A Komissarov, Maria Kislova, Ivan A Molodtsov
|Feb 14, 2022
COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study.Оlga L Kochneva, Maria Kislova, Evgenya I Zhelnova
Pageof 1
Frequent Collaborators
4 joint publications
Elena Dmitrieva
4 joint publications
Vadim V Ptushkin
4 joint publications
Eugene Nikitin
2 joint publications
Elena Vasilieva
2 joint publications
Andrei A Petrenko
1 joint publications
U P Ergasheva
1 joint publications
E P Panchenko
1 joint publications
C G Chernyshenko
1 joint publications
Y A Fedotkina
1 joint publications
E B Yarovaya
